Duration of antibody responses after severe acute respiratory syndrome

被引：298

作者：

Wu, Li-Ping

Wang, Nai-Chang

Chang, Yi-Hua

Tian, Xiang-Yi

Na, Dan-Yu

Zhang, Li-Yuan

Zheng, Lei

Lan, Tao

Wang, Lin-Fa

Liang, Guo-Dong ^{[1
]}

机构：

[1] Shanxi Prov Ctr Dis Control & Prevent, Taiyuan, Peoples R China

[2] Shanxi Prov Peoples Hosp, Taiyuan, Peoples R China

[3] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia

[4] Australian Biosecurity Ctr Emerging Infect Dis, Geelong, Vic, Australia

[5] State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China

来源：

EMERGING INFECTIOUS DISEASES | 2007年 / 13卷 / 10期

关键词：

D O I：

10.3201/eid1310.070576

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Among 176 patients who had had severe acute respiratory syndrome (SARS), SARS-specific antibodies were maintained for an average of 2 years, and significant reduction of immunoglobulin G-positive percentage and titers occurred in the third year. Thus, SARS patients might be susceptible to reinfection >= 3 years after initial exposure.

引用

页码：1562 / 1564

页数：3

共 15 条

[11] Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human [J].

Song, HD ;

Tu, CC ;

Zhang, GW ;

Wang, SY ;

Zheng, K ;

Lei, LC ;

Chen, QX ;

Gao, YW ;

Zhou, HQ ;

Xiang, H ;

Zheng, HJ ;

Chern, SWW ;

Cheng, F ;

Pan, CM ;

Xuan, H ;

Chen, SJ ;

Luo, HM ;

Zhou, DH ;

Liu, YF ;

He, JF ;

Qin, PZ ;

Li, LH ;

Ren, YQ ;

Liang, WJ ;

Yu, YD ;

Anderson, L ;

Wang, M ;

Xu, RH ;

Wu, XW ;

Zheng, HY ;

Chen, JD ;

Liang, GD ;

Gao, Y ;

Liao, M ;

Fang, L ;

Jiang, LY ;

Li, H ;

Chen, F ;

Di, B ;

He, LJ ;

Lin, JY ;

Tong, SX ;

Kong, XG ;

Du, L ;

Hao, P ;

Tang, H ;

Bernini, A ;

Yu, XJ ;

Spiga, O ;

Guo, ZM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2430-2435

[12] Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes [J].

Temperton, NJ ;

Chan, PK ;

Simmons, G ;

Zambon, MC ;

Tedder, RS ;

Takeuchi, Y ;

Weiss, RA .

EMERGING INFECTIOUS DISEASES, 2005, 11 (03) :411-416

[13]

Wang LF, 2006, EMERG INFECT DIS, V12, P1834

[14] Longitudinal profile of immunoglobulin G (IgG), IgM, and TgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus [J].

Woo, PCY ;

Lau, SKP ;

Wong, BHL ;

Chan, KH ;

Chu, CM ;

Tsoi, HW ;

Huang, Y ;

Peiris, JSM ;

Yuen, KY .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (04) :665-668

[15]

Word Health Organization, 2003, CAS DEF SURV SEV AC

← 1 2 →